Evidence map›Paper›PMID 35945669›Full record

ArticleJournal of biomedical optics2022

Subcellular analysis of nuclear and cytoplasmic redox indices differentiates breast cancer cell subtypes better than nuclear-to-cytoplasmic area ratio.

Annemarie Jacob, He N Xu, Andrea L Stout, Lin Z Li

Open access · goldAbstract read
In one paragraph

Article in Journal of biomedical optics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Passage dependence of NADH redox status and reactive oxygen species levelTranslational breast cancer research : a journal focusing on translational research in breast cancer · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Annemarie JacobUniversity of Pennsylvania, Perelman School of Medicine, Department of Radiology, Britton Chance Laboratory of Redox Imaging, Philadelphia, Pennsylvania, United States, United States.
He N XuUniversity of Pennsylvania, Perelman School of Medicine, Department of Radiology, Britton Chance Laboratory of Redox Imaging, Philadelphia, Pennsylvania, United States, United States.
Andrea L StoutUniversity of Pennsylvania, Perelman School of Medicine, Department of Cell and Developmental Biology, Philadelphia, Pennsylvania, United States, United States.
Lin Z LiUniversity of Pennsylvania, Perelman School of Medicine, Department of Radiology, Britton Chance Laboratory of Redox Imaging, Philadelphia, Pennsylvania, United States, United States.
University of Pennsylvania · US

Funding

Phenotypic Diversity in COVID-19UL1TR001878 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2016 to 2025
$102.4M
Redox imaging for breast cancer prognosisR01CA191207 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LI, LIN Z · 2015 to 2019
$3.2M
NCATS NIH HHS UL1 TR001878NCI NIH HHS R01 CA191207
6 · The paper itself

Abstract

significanceStratification of malignancy is valuable for cancer treatment. Both optical redox imaging (ORI) indices and nuclear-to-cytoplasmic volume/area ratio (N:C ratio) have been investigated to differentiate between cancers with varying aggressiveness, but these two methods have not been directly compared. The redox status in the cell nucleus has not been studied by ORI, and it remains unknown whether nuclear ORI indices add new biological information.

aimWe sought to compare the capacity of whole-cell and subcellular ORI indices and N:C ratio to differentiate between breast cancer subtypes with varying aggressiveness and between mitotic and nonmitotic cells. APPROACH: ORI indices for whole cell, cytoplasm, and nucleus as well as the N:C area ratio were generated for two triple-negative (more aggressive) and two receptor-positive (less aggressive) breast cancer cell lines by fluorescence microscopy.

resultsWe found positive correlations between nuclear and cytoplasmic ORI indices within individual cells. On average, a nuclear redox status was found to be more oxidized than cytoplasm in triple-negative cells but not in receptor-positive cells. Whole-cell and subcellular ORI indices distinguished between the receptor statuses better than the N:C ratio. However, N:C ratio was a better differentiator between nonmitotic and mitotic triple-negative cells.

conclusionsSubcellular ORI analysis differentiates breast cancer subtypes with varying aggressiveness better than N:C area ratio.

Indexed as

Breast NeoplasmsCell NucleusCytoplasmFemaleHumansMCF-7 CellsOxidation-Reductionaggressivenessflavin adenine dinucleotidemitosisoptical redox imagingreduced nicotinamide adenine dinucleotidetriple-negative breast cancer

Identifiers

PMID35945669
PMCPMC9360498
OpenAlexW4290737497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.